Profile picture

Doctor Jonathan Tjerkaski

Karolinska Institute, Stockholm (Sweden)
Follow
Logo ESC

Contributor content

The effect of Glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in type 2 diabetes mellitus patients with coronary artery disease
Presentation
The effect of Glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in type 2 diabetes mellitus patients with coronary artery disease
Read more
Comparison of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in myocardial infarction patients with type 2 diabetes
Presentation
Comparison of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in myocardial infarction patients with type 2 diabetes
Read more
Comparison between ticagrelor and clopidogrel in high bleeding risk patients with acute coronary syndrome
Presentation
Comparison between ticagrelor and clopidogrel in high bleeding risk patients with acute coronary syndrome
Read more

ESC 365 is supported by

novartis Explore sponsored resources